Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O. Ultsch B, et al. Pharmacoeconomics. 2016 Mar;34(3):227-44. doi: 10.1007/s40273-015-0335-2. Pharmacoeconomics. 2016. PMID: 26477039 Free PMC article.
Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-Workshop.
Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote AU, Greiner W, Hanquet G, Harder T, Hutubessy R, Jit M, Knol M, Kuhlmann A, von Kries R, Levy-Bruhl D, Perleth M, Postma MJ, Salo H, Siebert U, Wasem J, Weidemann F, Wichmann O. Ultsch B, et al. Value Health. 2014 Nov;17(7):A552. doi: 10.1016/j.jval.2014.08.1803. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201800 Free article. No abstract available.
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries.
EUnetHTA Joint Action 2, Work Package 7, Subgroup 3; Heintz E, Gerber-Grote A, Ghabri S, Hamers FF, Rupel VP, Slabe-Erker R, Davidson T. EUnetHTA Joint Action 2, Work Package 7, Subgroup 3, et al. Pharmacoeconomics. 2016 Jan;34(1):59-76. doi: 10.1007/s40273-015-0328-1. Pharmacoeconomics. 2016. PMID: 26446858 Review.
Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants.
Seidl A, Danner M, Wagner CJ, Sandmann FG, Sroczynski G, Stürzlinger H, Zsifkovits J, Schwalm A, Lhachimi SK, Siebert U, Gerber-Grote A. Seidl A, et al. Among authors: gerber grote a. MDM Policy Pract. 2018 Jan 10;3(1):2381468317751923. doi: 10.1177/2381468317751923. eCollection 2018 Jan-Jun. MDM Policy Pract. 2018. PMID: 30288435 Free PMC article.
The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?
Sandmann FG, Mostardt S, Lhachimi SK, Gerber-Grote A. Sandmann FG, et al. Among authors: gerber grote a. Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):475-486. doi: 10.1080/14737167.2018.1497976. Epub 2018 Jul 18. Expert Rev Pharmacoecon Outcomes Res. 2018. PMID: 29979895 Free article.
32 results